Genome & Company (KOSDAQ:314130)
2,910.00
 +55.00 (1.93%)
  At close: Oct 28, 2025
1.93% (1Y)
| Market Cap | 99.94B | 
| Revenue (ttm) | 24.02B | 
| Net Income (ttm) | -27.08B | 
| Shares Out | 31.09M | 
| EPS (ttm) | -875.42 | 
| PE Ratio | n/a | 
| Forward PE | n/a | 
| Dividend | n/a | 
| Ex-Dividend Date | n/a | 
| Volume | 232,563 | 
| Average Volume | 172,497 | 
| Open | 2,860.00 | 
| Previous Close | 2,855.00 | 
| Day's Range | 2,840.00 - 2,950.00 | 
| 52-Week Range | 2,170.00 - 3,845.00 | 
| Beta | 1.13 | 
| RSI | 56.22 | 
| Earnings Date | Nov 14, 2025 |